A1BD3
enprofylline
| Created: | 2024-10-22 |
| Last modified: | 2024-10-30 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 24 |
| Chiral Atom Count | 0 |
| Bond Count | 25 |
| Aromatic Bond Count | 5 |
Chemical Component Summary | |
|---|---|
| Name | enprofylline |
| Systematic Name (OpenEye OEToolkits) | 3-propyl-7~{H}-purine-2,6-dione |
| Formula | C8 H10 N4 O2 |
| Molecular Weight | 194.191 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 14.52 | O=C1NC(=O)N(CCC)c2nc[NH]c21 |
| SMILES | CACTVS | 3.385 | CCCN1C(=O)NC(=O)c2[nH]cnc12 |
| SMILES | OpenEye OEToolkits | 3.1.0.0 | CCCN1c2c([nH]cn2)C(=O)NC1=O |
| Canonical SMILES | CACTVS | 3.385 | CCCN1C(=O)NC(=O)c2[nH]cnc12 |
| Canonical SMILES | OpenEye OEToolkits | 3.1.0.0 | CCCN1c2c([nH]cn2)C(=O)NC1=O |
| InChI | InChI | 1.06 | InChI=1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14) |
| InChIKey | InChI | 1.06 | SIQPXVQCUCHWDI-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB00824 |
|---|---|
| Name | Enprofylline |
| Groups |
|
| Description | Enprofylline is a derivative of theophylline which shares bronchodilator properties. Enprofylline is used in asthma, chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. Long-term enprofylline administration may be associated with elevation in liver enzyme levels and unpredictable blood levels. |
| Synonyms |
|
| Indication | Used in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. |
| Categories |
|
| CAS number | 41078-02-8 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| 3',5'-cyclic-AMP phosphodiesterase 4B | MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNL... | unknown | inhibitor |
| 5'-nucleotidase | MCPRAARAPATLLLALGAVLWPAAGAWELTILHTNDVHSRLEQTSEDSSK... | unknown | inhibitor |
| Adenosine receptor A2b | MLLETQDALYVALELVIAALSVAGNVLVCAAVGTANTLQTPTNYFLVSLA... | unknown | antagonist |
| 3',5'-cyclic-AMP phosphodiesterase 4A | MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSD... | unknown | inhibitor |
| Adenosine receptor A1 | MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVS... | unknown | inhibitor |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 1676 |
| ChEMBL | CHEMBL279898 |
| ChEBI | CHEBI:126237 |














